Kamada (KMDA) Cash from Investing Activities (2013 - 2026)

Kamada (KMDA) posted quarterly Cash from Investing Activities of -$41.2 million for Q1 2026, down 2721.78% year-on-year from $1.6 million in Q1 2025, and down 1384.61% on a QoQ basis from -$2.8 million in Q4 2025.

Kamada (KMDA) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Kamada (KMDA) has reported Cash from Investing Activities for 14 consecutive years, with -$41.2 million the latest figure, recorded in Q1 2026.

  • Quarterly Cash from Investing Activities fell 2721.78% year-over-year to -$41.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49.6 million (down 420.92% YoY) and the FY2025 annual result came in at -$9.8 million, up 8.39% from the prior year.
  • Cash from Investing Activities declined to -$41.2 million in Q1 2026 per KMDA's latest filing, from -$2.8 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for KMDA reached as high as -$1093.0 in Q1 2023 and fell as low as -$41.2 million in Q1 2026.
  • A 5-year average of -$4.0 million and a median of -$2.0 million in 2023 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities surged 99.79% — and 2024, when it sank 245279.69%.
  • Year by year, Cash from Investing Activities stood at -$977000.0 in 2022, then sank by 101.94% to -$2.0 million in 2023, then tumbled by 48.2% to -$2.9 million in 2024, then gained by 5.1% to -$2.8 million in 2025, then plunged by 1384.61% to -$41.2 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$41.2 million, -$2.8 million, and -$3.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -60.00 Mn
10 Kamada 399.49 Mn 326.34 Mn 19.12 Mn -41.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -41.20 Mn
Mar 31, 2026 -41.20 Mn
Dec 31, 2025 -2.78 Mn
Dec 31, 2025 -2.78 Mn
Sep 30, 2025 -3.59 Mn
Sep 30, 2025 -3.59 Mn
Jun 30, 2025 -2.01 Mn
Jun 30, 2025 -2.01 Mn
Mar 31, 2025 -1.46 Mn
Mar 31, 2025 -1.46 Mn
Dec 31, 2024 -2.92 Mn
Dec 31, 2024 -2.92 Mn
Sep 30, 2024 -2.12 Mn
Sep 30, 2024 -2.12 Mn
Jun 30, 2024 -3.01 Mn
Jun 30, 2024 -3.01 Mn
Mar 31, 2024 -2.68 Mn
Mar 31, 2024 -2.68 Mn
Dec 31, 2023 -1.97 Mn
Dec 31, 2023 -1.97 Mn